T1aN0M0甲状腺乳头状癌微波消融与手术切除10年随访比较
本研究为单中心回顾性分析,纳入134例单灶T1aN0M0甲状腺乳头状癌患者,比较超声引导下微波消融与手术切除的10年结局。两组疾病进展生存无统计学显著差异,微波消融组总体并发症发生率数值上较低且均为暂时性,永久性并发症仅见于手术组。
要点
- 微波消融组10年疾病进展生存与手术组无统计学显著差异
- 微波消融组并发症均为暂时性,永久性并发症仅见于手术组
- 微波消融可保留甲状腺功能,无需甲状腺激素替代治疗
核心结论
- 长期随访提示超声引导下微波消融可作为除手术切除外,针对选择性单灶T1aN0M0甲状腺乳头状癌患者安全有效的治疗选择
研究设计与样本
- 单中心回顾性分析,纳入134例单灶T1aN0M0甲状腺乳头状癌患者,入组时间为2014年6月至10月,接受超声引导下微波消融或手术切除,中位年龄43.53±9.19岁,其中99例为女性,完成120个月完整随访
关键影像表现/征象
- 微波消融组甲状腺功能得以保留,无需甲状腺激素替代治疗
诊断标准与关键数值
- 主要终点为局部肿瘤复发、新发肿瘤、远处转移和淋巴结转移,两组疾病进展生存无统计学显著差异
- 次要终点为消融区体积缩小率及操作相关并发症发生率,微波消融组总体并发症发生率数值上低于手术组
临床应用与阅片要点
- 对选择性单灶T1aN0M0甲状腺乳头状癌患者,超声引导下微波消融可作为一种侵袭性较小的治疗选项纳入临床决策
- 微波消融在保留正常甲状腺功能、避免终身激素替代方面具有潜在优势
- 基线人口学与临床特征在两组间均衡,支持两组比较的有效性
局限性
- 单中心回顾性设计
- 原文提示需进一步研究验证这些初步结果
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the long-term oncological outcomes and safety of ultrasound-guided microwave ablation (MWA) compared to surgical resection (SR) for unifocal T1aN0M0 papillary thyroid carcinoma (PTC).
MATERIALS AND METHODS: This single-center retrospective analysis enrolled 134 patients with unifocal T1aN0M0 papillary thyroid carcinoma who underwent either ultrasound-guided MWA or SR between June and October 2014. Baseline demographic and clinical characteristics were well-balanced between the two cohorts. Primary endpoints included local tumor recurrence, new tumor, distant metastasis, and lymph node metastasis. Secondary endpoints comprised the volume reduction rate of the ablation zone and the incidence of procedure-related complications.
RESULTS: A total of 134 patients (mean age 43.53 ± 9.19 years, 99 females) were included in this study and followed for a complete period of 120 months. No statistically significant difference was observed in disease progression-free survival between the MWA and SR groups. The MWA group demonstrated a numerically lower overall complication rate compared to the SR group, with the majority of complications being transient. Permanent complications occurred only in the SR group.
CONCLUSION: Long-term follow-up suggests that ultrasound-guided MWA could be considered a safe and effective therapeutic choice in addition to SR for selected patients with unifocal T1aN0M0 PTC.
KEY POINTS: Question What are the 10-year outcomes of ultrasound-guided MWA versus SR in patients with unifocal T1aN0M0 papillary thyroid carcinoma? Findings During long-term follow-up of patients treated with ultrasound-guided MWA, normal thyroid function was preserved without thyroid hormone replacement therapy. No permanent procedure-related complications were documented in the observation period. Clinical relevance These findings suggest that MWA could be considered as a treatment option in addition to SR for selected patients with unifocal T1aN0M0 PTC, potentially enabling a less invasive management approach. Further investigation is warranted to validate these preliminary results.
引用
- Wang, Sui, Wang, et al. Microwave ablation versus surgical resection for unifocal T1aN0M0 papillary thyroid carcinoma: a 10-year follow-up study. Eur Radiol. 2026. PMID: 42470479. doi:10.1007/s00330-026-12724-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。